InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,065.56
(
-0.10%
)
US TECH 100
17,045.20
(
0.25%
)
Dow Jones
38,390.94
(
-0.29%
)
Brent Oil
87.43
(
-0.16%
)
Bitcoin
65,023.73
(
-2.09%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Dragon Lady

Send PM Follow Ignore
Followers 371
Posts 16733
Boards Moderated 3
Alias Born 03/07/2014

Dragon Lady

Re: None

Sunday, 05/24/2015 4:24:11 PM

Sunday, May 24, 2015 4:24:11 PM

Post# of 92948
Quote FALSE LOL, "The Biotech history, very clearly shows phase2 runs-run. OCAT had phase1 run to $27 "fact"."

NO "fact"???

OCAT "went public" via the "poor man's" way (as the company was cash broke as they've essentially always been)- via a reverse merger STRAIGHT TO THE OTC market using the guts of the TWO MOONS KACHINA DOLL COMPANY OF UTAH.

That public share price, 10 years ago in 2005 was about $5.00 per share. They have never, ever traded higher than about $5.00 per share, split adjusted. The common shares have since lost approx. 99% of their value- from $5.00 a share, to a R/S split adjusted price today of about 6 CENTS to maybe 7 CENTS. FACT.

http://www.nature.com/news/stem-cell-research-never-say-die-1.9759

The entire sorted tale of ACT/OCAT as told by the highly respected journal, "NATURE".

Posts contain only my amateur opinions, personal views and thoughts. I discuss stocks as a hobby only. Always do one's own due diligence before investing.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up